Safety, Tolerability, and Pharmacokinetics of a Subcutaneous and Intravenous Dose of BI 655130 in Healthy Subjects
Clinical trial NCT03100903 · COMPLETED
Trial details
- NCT number
- NCT03100903
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-24
- Primary completion
- 2018-01-10
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.